Form 4 Tracker
Axsome Therapeutics, Inc.
AXSM

34 insider filings · Latest: Aug 5, 2026

Common Stock Transactions
Txn DateAcceptedInsiderTypeSharesAvg PriceValueShares OwnedFiling
Sep 12, 2025Sep 12 11:19 PMHerriot Tabuteau
Proposed Sale
27,907$118.42$3.3M

View →

Sep 5, 2025Sep 5 9:08 PMSaad Mark E
Proposed Sale
9,127$125.07$1.1M

View →

Sep 2, 2025Sep 2 8:01 PMJEFFS ROGER
Proposed Sale
13,464$123.68$1.7M

View →

Aug 29, 2025Aug 29 8:02 PMJEFFS ROGER
Proposed Sale
20,000$121.27$2.4M

View →

Aug 28, 2025Aug 28 8:04 PMJEFFS ROGER
Proposed Sale
20,000$121.60$2.4M

View →

Aug 27, 2025Aug 27 8:12 PMJEFFS ROGER
Proposed Sale
20,000$122.30$2.4M

View →

Aug 26, 2025Aug 26 8:08 PMJEFFS ROGER
Proposed Sale
20,000$120.03$2.4M

View →

Aug 22, 2025Aug 22 8:28 PMJEFFS ROGER
Proposed Sale
16,694$120.08$2.0M

View →

Jun 23, 2025Jun 23 8:01 PMMurdock Hunter R.
Proposed Sale
6,014$100.12$602.1K

View →

Jun 20, 2025Jun 20 8:08 PMMurdock Hunter R.
Proposed Sale
7,500$102.47$768.5K

View →

Jun 18, 2025Jun 18 8:42 PMMurdock Hunter R.
Proposed Sale
7,500$100.90$756.7K

View →

Jun 17, 2025Jun 17 8:01 PMMurdock Hunter R.
Proposed Sale
7,500$100.26$752.0K

View →

Jun 16, 2025Jun 16 8:17 PMMurdock Hunter R.
Proposed Sale
7,500$102.42$768.2K

View →

Jun 9, 2025Jun 9 8:07 PMJacobson Mark L.
Proposed Sale
25,000$110.44$2.8M

View →

May 28, 2025May 28 9:04 PMColeman Mark
Proposed Sale
3,750$103.43$387.9K

View →

May 28, 2025May 28 9:03 PMJacobson Mark L.
Proposed Sale
20,000$103.45$2.1M

View →

May 27, 2025May 27 8:46 PMJacobson Mark L.
Proposed Sale
20,673$0.00$1

View →

May 27, 2025May 27 8:45 PMColeman Mark
Proposed Sale
3,750$105.47$395.5K

View →

May 20, 2025May 20 9:54 PMColeman Mark
Proposed Sale
3,000$107.49$322.5K

View →

Feb 14, 2025Feb 14 9:09 PMPizzie Nick
Proposed Sale
3,000$131.07$393.2K

View →

Stock Options & Derivatives
Txn DateAcceptedInsiderTypeSharesExercise PriceShares OwnedFiling
Apr 21, 2026Apr 24 1:00 AMHunter R. MurdockGeneral Counsel
Grant/Award
7,2247,224(D)

View →

Feb 26, 2026Feb 28 12:10 AMTABUTEAU HERRIOTDirector, Chief Executive Officer, 10% Owner
Grant/Award
54,62354,623(D)

View →

Feb 26, 2026Feb 28 12:10 AMNick PizzieChief Financial Officer
Grant/Award
18,57018,570(D)

View →

Feb 26, 2026Feb 28 12:10 AMHunter R. MurdockGeneral Counsel
Grant/Award
16,38516,385(D)

View →

Feb 26, 2026Feb 28 12:10 AMAri MaizelChief Commercial Officer
Grant/Award
16,38516,385(D)

View →

Feb 26, 2026Feb 28 12:10 AMMark L. JacobsonChief Operating Officer
Grant/Award
19,66319,663(D)

View →

Feb 26, 2026Feb 28 12:00 AMMark L. JacobsonChief Operating Officer
Option Exercise
35,378$2.850(D)

View →

Feb 23, 2026Feb 26 12:00 AMMark ColemanDirector
Option Exercise
6,250$4.957,721(D)

View →

Feb 20, 2026Feb 24 12:23 AMMark ColemanDirector
Option Exercise
12,485$4.9513,971(D)

View →

Feb 10, 2026Feb 11 12:11 AMMark ColemanDirector
Option Exercise
5,193$8.020(D)

View →

Feb 2, 2026Feb 2 11:30 PMTABUTEAU HERRIOTDirector, Chief Executive Officer, 10% Owner
Option Exercise
32,410$185.600(D)

View →

Jan 22, 2026Jan 24 12:00 AMNick PizzieChief Financial Officer
Option Exercise
12,000$3.50105,000(D)

View →

Jan 21, 2026Jan 24 12:00 AMAri MaizelChief Commercial Officer
Option Exercise
7,500$70.7331,210(D)

View →

← Previous

Page 2 of 2